Fundz

Alucent Biomedical reported raising $11.2 Million in an initial SEC Form D filing, from an offering of $11.2 Million

PRIVATEApr 20, 2023

Amount Raised

$11.2 Million

$11.2 Million sold, per SEC Form D (first sale Apr 17, 2023)

Round Type

Venture

Salt Lake CityBiotechnology

Quick answer

Alucent Biomedical, Inc. raised $11.2 Million in a funding round, dated April 17, 2023. Alucent Biomedical, Inc. is based in Salt Lake City, Utah, United States.

How much did Alucent Biomedical, Inc. raise?
Alucent Biomedical, Inc. raised $11.2 Million in a funding round on April 17, 2023.
What does Alucent Biomedical, Inc. do?
Alucent Medical, Inc. is a privately-held biotechnology company, based in Salt Lake City, UT, developing a novel drug-device combination therapy, Natural Vascular Scaffolding (NVS) for patients with peripheral vascular..
Where is Alucent Biomedical, Inc. based and how big is it?
Alucent Biomedical, Inc. is based in Salt Lake City, Utah, United States.
Who are the decision-makers at Alucent Biomedical, Inc?
Fundz holds 1 contact at Alucent Biomedical, Inc., including the Study Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Alucent Biomedical, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • VLX-1005 raised $24M on June 1, 2023.
  • Kanvas Biosciences raised $12M on June 1, 2023.
  • selectIon raised $5M on May 31, 2023.
  • Telesis Bio raised an undisclosed amount (Funding Round) on May 31, 2023.
  • Azora Therapeutics, Inc. (DE) raised $53K (Pre-Seed) on May 31, 2023.
  • Biophysical Therapeutics raised $100K (Pre-Seed) on May 31, 2023.

Who to call at Alucent Biomedical, Inc., and when

A new round usually means Alucent Biomedical, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Alucent Biomedical, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alucent Biomedical, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Alucent Biomedical, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Alucent Biomedical, Inc.

Location

675 ARAPEEN DRIVE, SUITE 102

Salt Lake City, Utah, United States

About

Alucent Medical, Inc. is a privately-held biotechnology company, based in Salt Lake City, UT, developing a novel drug-device combination therapy, Natural Vascular Scaffolding (NVS) for patients with peripheral vascular disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Alucent Biomedical, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsHenry H., Study Director hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Alucent Biomedical, Inc.'s next move

See what Strategic adds

Alucent Biomedical, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.